pH-responsive CDs-based nanoplatform for chemo-resistant esophageal cancer treatment via downregulation of HIF-1α related pathway
Xuewei Wang, Yue Zhang, Hao Wu, Zelei Yang, Sufang Ma, Lihong Li, Lixia Guo, Lili Yan, Boye Zhang, Jianfei Liu, Haipeng Diao, Guodong Ren, Chengwu Zhang, Wen Liu · 2026
Read pH-responsive CDs-based nanoplatform for chemo-resistant esophageal cancer treatment via downregulation of HIF-1α related pathway by Xuewei Wang, Yue Zhang, Hao Wu, Zelei Yang, Sufang Ma, Lihong Li, Lixia Guo, Lili Yan, Boye Zhang, Jianfei Liu, Haipeng Diao, Guodong Ren, Chengwu Zhang, Wen Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471539.txt.
Description
Wang and co-authors engineered a nanoparticle that releases its chemotherapy cargo only in the acidic surroundings of a tumor, aiming at drug-resistant esophageal cancer. Their 2026 study built the platform from iron-doped carbon dots carrying doxorubicin plus glucose oxidase, an enzyme that starves and acidifies tumor cells, and tested it in resistant cells and mouse tumors.
The release switch worked sharply: at pH 6.5, mimicking tumor acidity, 60.4% of the doxorubicin escaped, against only 22.7% released at normal body pH of 7.4 in the same tests. Drug loading reached 21.5% for the carbon dots' partner cargo and 16.1% for doxorubicin by weight. The particles also dimmed HIF-1α, a resistance driver unusually high in the squamous type behind over 90% of cases.
Catalog record
| CREATOR | Xuewei Wang, Yue Zhang, Hao Wu, Zelei Yang, Sufang Ma, Lihong Li, Lixia Guo, Lili Yan, Boye Zhang, Jianfei Liu, Haipeng Diao, Guodong Ren, Chengwu Zhang, Wen Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |